Alcon partners with NFL star Cooper Kupp on eye allergy campaign

Article

The new partnership supports Alcon's Pataday Once Daily Relief Extra Strength eye drops as treatment for eye allergies.

Alcon and Cooper Kupp, a wide receiver on the NFL's Los Angeles Rams team, have partnered on a new campaign spotlighting eye allergy treatment, the company announced Monday.

Cooper Kupp

Image courtesy of @cooperkupp via Instagram


The partnership supports Alcon's Pataday Once Daily Relief Extra Strength, which is the first 24-hour allergy itch relief eye drop available in the US without a prescription.

Kupp will participate in the "The Right Tool for the Job" full-scale media campaign, which will highlight his personal history of eye allergy symptoms and seeking relief treatment with Alcon's product, as well as encourage consumers to use the drops for their own eyeallergy relief.

Alcon's Pataday Once Daily Relief Extra Strength

Image courtesy of Alcon

In a statement, he shared how seasonal allergy flare ups and pollen have often lead to him suffering from itchy eyes—a distraction during training camp and on the field during games. The drops have since allowed him to control his symptoms.

As an antihistamine eye drop, Pataday works by offering fast and long-lasting allergy itch relief to those experiencing allergic conjunctivits, according to the company.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.